Tesaro, Inc. (NASDAQ:TSRO) Rating Changes as of Jun 27, 2018

June 27, 2018 - By Alex Paulin

Tesaro, Inc. (NASDAQ:TSRO) Corporate Logo
During 2018 Q1 the big money sentiment increased to 1.14. That’s change of 0.13, from 2017Q4’s 1.01. 41 investors sold all, 58 reduced holdings as Tesaro, Inc. ratio improved. 80 increased positions while 33 funds bought positions. Funds hold 60.57 million shares thus 4.53% more from 2017Q4’s 57.95 million shares.
6,887 are held by Utah Retirement System. Schwab Charles Inv has invested 0.01% in Tesaro, Inc. (NASDAQ:TSRO). First Republic Investment Mngmt invested in 0% or 4,517 shs. Voya Investment Management Limited Liability Com owns 13,447 shs. New Jersey-based Prudential Inc has invested 0% in Tesaro, Inc. (NASDAQ:TSRO). North Carolina-based Bancorp Of America De has invested 0% in Tesaro, Inc. (NASDAQ:TSRO). Renaissance Technology Lc reported 186,500 shs. Grp One Trading Ltd Partnership holds 0.03% or 50,140 shs. Stifel Fincl holds 0% in Tesaro, Inc. (NASDAQ:TSRO) or 4,095 shs. Susquehanna Intll Llp owns 84,165 shs or 0% of their US capital. Artal Grp Sa has invested 0.43% in Tesaro, Inc. (NASDAQ:TSRO). Hillhouse Mngmt Limited stated it has 0.04% of its capital in Tesaro, Inc. (NASDAQ:TSRO). Barclays Public Limited Co has invested 0% in Tesaro, Inc. (NASDAQ:TSRO). Sumitomo Mitsui reported 0.01% stake. Dekabank Deutsche Girozentrale stated it has 0.04% of its capital in Tesaro, Inc. (NASDAQ:TSRO).

Tesaro, Inc. registered $60.88 million net activity with 9 buys and 8 sales since March 1, 2018. On Friday, March 2 the insider BASKETT FOREST bought $8.35M. $98,913 worth of Tesaro, Inc. (NASDAQ:TSRO) was sold by Huber Martin H. Jr. on Thursday, March 1. Shares for $6.68 million were bought by NEW ENTERPRISE ASSOCIATES 13 LP on Friday, March 2. $8.35M worth of Tesaro, Inc. (NASDAQ:TSRO) was bought by BARRIS PETER J. Shares for $6.68M were bought by BARRETT M JAMES. 2,575 shs valued at $141,265 were sold by PEARSON TIMOTHY R on Thursday, March 1.

Tesaro, Inc. (NASDAQ:TSRO) Ratings Coverage

In total 15 analysts cover Tesaro (NASDAQ:TSRO). “Buy” rating has 12, “Sell” are 0, while 3 are “Hold”. 80% are bullish. 18 are the (NASDAQ:TSRO)’s analyst reports since January 3, 2018 according to StockzIntelligence Inc. On Wednesday, February 28 the firm has “Buy” rating by Wells Fargo given. On Wednesday, February 28 the firm has “Buy” rating given by Leerink Swann. On Wednesday, May 2 the firm has “Buy” rating given by Argus Research. On Friday, May 4 the firm has “Buy” rating given by Bank of America. The company rating was maintained by Piper Jaffray on Monday, April 16. On Friday, May 4 the firm has “Outperform” rating by Credit Suisse given. On Friday, May 4 H.C. Wainwright maintained the shares of TSRO in report with “Buy” rating. On Wednesday, February 28 the stock of Tesaro, Inc. (NASDAQ:TSRO) has “Equal-Weight” rating given by Barclays Capital. On Tuesday, March 27 the stock of Tesaro, Inc. (NASDAQ:TSRO) has “Buy” rating given by Wedbush. The company rating was maintained by Morgan Stanley on Thursday, March 1. Listed here are Tesaro, Inc. (NASDAQ:TSRO) PTs and latest ratings.

31/05/2018 Broker: Citigroup Rating: Buy New Target: $100.0000 Maintain
07/05/2018 Broker: Lake Street Rating: Buy New Target: $80.0000 Maintain
04/05/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $94 New Target: $88 Maintain
04/05/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $141 New Target: $128 Maintain
04/05/2018 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $102 New Target: $100 Maintain
04/05/2018 Broker: H.C. Wainwright Rating: Buy New Target: $104.0000 Maintain
02/05/2018 Broker: Argus Research Old Rating: Buy New Rating: Buy Old Target: $154 New Target: $110 Maintain
16/04/2018 Broker: Piper Jaffray Rating: Hold Maintain
27/03/2018 Broker: Wedbush Rating: Buy New Target: $76.0000 Maintain
28/02/2018 Broker: Cowen & Co Rating: Hold New Target: $66.0 Maintain

Ticker’s shares touched $43.5 during the last trading session after 0.25% change.Tesaro, Inc. has volume of 278,840 shares. Since June 27, 2017 TSRO has declined 66.21% and is downtrending. The stock underperformed the S&P500 by 78.78%.

Tesaro, Inc., an oncology-focused biopharmaceutical company, identifies, acquires, develops, and commercializes cancer therapeutics and oncology supportive care products in the United States.The company has $2.39 billion market cap. It markets Rolapitant, a neurokinin-1, or NK-1, receptor antagonist for the prevention of chemotherapy induced nausea and vomiting under the VARUBI brand name.Currently it has negative earnings. The firm is also developing Niraparib, an orally active and potent poly polymerase inhibitor, which is in various clinical trials to treat ovarian or breast cancers.

For more Tesaro, Inc. (NASDAQ:TSRO) news brought out recently go to: Seekingalpha.com, Seekingalpha.com, Fool.com, Seekingalpha.com or Nasdaq.com. The titles are as follows: “Tesaro: Was That The Bottom?” brought out on June 25, 2018, “Tesaro: Consider Calls” on June 19, 2018, “ASCO Conference Preview: Here’s What Biotech Investors Need to Watch” with a publish date: May 31, 2018, “Tesaro: Can Upcoming Catalyst Bring Fortune To This Unpopular Company?” and the last “Why Winnebago Industries, Synaptics, and Tesaro Jumped Today” with publication date: June 20, 2018.

Tesaro, Inc. (NASDAQ:TSRO) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.